HIPRA

💡Carla Romero, Demand Planning Supervisor at HIPRA, shares a powerful message with her younger self: follow your passion, because the future is yours! Despite being a minority in the classroom, she believed in herself and proved that women bring talent and a unique perspective to science and technology. Today, she is fulfilled doing what she has always been passionate about and inspires others to do the same. 🎥Don’t miss her story! #HIPRApeople #WomenAndGirlsInScience #WomenInSTEM

Today, we had the honor of welcoming the Secretary of State for Health of the Government of Spain, Javier Padilla, and discussing the present and future of health in Spain and Europe, where vaccines play a strategic role in a global context full of challenges. Five years ago, the pandemic tested our capacity for innovation and response. At HIPRA, we took on the challenge with determination. This experience has reinforced our belief in the importance of research and the production of biotechnological solutions to ensure a rapid and effective response to future challenges. This commitment continues to guide us. We remain dedicated to developing cutting-edge solutions in human and animal health, driving innovation, and collaborating with institutions and organizations to build a more prepared and resilient Europe. Thank you, Javier Padilla, for your visit and for your support of health research and innovation. #Healthcare #Innovation #StrategicAutonomy

🌍 All systems go for HIPRA Biotech Services’ participation in #DCATWeek 2025 in New York, from March 17 to 20! 🔬 #HIPRA Biotech Services is our biologics Contract Development and Manufacturing Organization (#CDMO), bringing 50 years of HIPRA’s experience, scientific and technical excellence, and state-of-the-art facilities to biotech and pharma clients. 💡 We offer capacity in Mammalian, Microbial, and Aseptic Fill & Finish, covering the entire process from cell line development to commercial manufacturing. 📅 We still have available meeting slots! Don’t miss the chance to explore our CDMO offering and discuss potential collaborations. Schedule a meeting with us via the link below. See you at #DCATWeek!

Did you know that only 63% of working-age women are part of the labor force, compared to 92% of men? Despite the progress made, this gap shows that there is still a long way to go (UN Women, 2025). At HIPRA, we join the #8M commemoration under the motto “For all women and girls: Rights. Equality. Empowerment”, as part of the campaign led by the UN Women. This year is particularly significant as we celebrate 30 years of The Beijing Declaration and Platform for Action, the most ambitious roadmap for achieving gender equality on a global scale. Today and every day, we reaffirm our commitment to equal opportunities. Only by working together can we build a fairer and more equitable future for everyone. Let’s move forward together towards equality!💜 #ForAllWomenAndGirls #IWD2025 #HIPRApeople

🐥 We’ll be at #VIVAsia in Bangkok! Discover our latest innovations in #hatchery vaccination and connect with industry colleagues. 📍 Meet us at the HIPRA meeting point at the Royal Pas Reform booth (2-2710) for the best solutions in #AnimalHealth! #PoultryIndustry #PoultryVaccines #VIVAsia2025

🌍In an increasingly interconnected world facing global challenges, Europe's strategic autonomy in biomedicine and biotechnology is more crucial than ever. The pandemic has taught us that our ability to respond effectively relies heavily on our self-sufficiency in healthcare, research, and production. In this context, the biotechnology industry -and more specifically, the vaccine sector- plays a key role in achieving this European objective. Furthermore, a resilient healthcare ecosystem must embrace a holistic approach. The #OneHealth perspective is essential for tackling emerging health threats. At HIPRA, we integrate this vision into our work, strengthening Europe's capacity to prevent and respond to future challenges. We are ready to play our part.🚀 #Healthcare #Innovation #StrategicAutonomy #EuropeanUnion

💬"If you believe in yourself and nurture your talent, you will go far. You will be part of a change, a change that will help transform the world." This week, as part of the International Day of Women and Girls in Science initiative, we highlight the inspiring journey of Míriam Costa, Manufacturing Supervisor Process Maintenance at HIPRA. In a heartfelt letter to her younger self, she reflects on confidence, perseverance, and becoming a role model for future generations. 🎥Watch the video and be inspired by her words! #HIPRApeople #WomenAndGirlsInScience #WomenInSTEM

🔬👩💻Inspiring future STEM generations: Mercedes’ journey in computer science This is the story of Mercedes Cabrera, IT Applications & Project Specialist, who shares how she discovered her passion for technology. What excites her most about this field is the ability to create, turning a blank canvas into an application or a functionality that benefits society. Through this initiative, we want to continue amplifying the voices of our STEM colleagues and inspiring future generations to pursue careers in science, technology, engineering, and mathematics. 🎥Don’t miss her story! #HIPRApeople #WomenAndGirlsInScience #WomenInSTEM

🚀Driving innovation in biotechnological services for a stronger Europe As highlighted in the Competitiveness Compass, fostering sectors like biotechnology is essential to strengthening Europe’s industrial strength, innovation capacity, and strategic autonomy. With HIPRA Biotech Services, our new specialized CDMO unit, we are dedicated to enhancing Europe's biopharmaceutical ecosystem and decisively contributing to its innovation agenda by providing cutting-edge capabilities in the development and manufacturing of biologics. Our mission? To strengthen Europe’s strategic autonomy in biotechnology, accelerate innovation, and contribute to our One Health vision, ensuring a healthier future for all. 🔬Let’s shape the future of biotech together! Read more about the Competitiveness Compass here: https://lnkd.in/dZ9pebC3 #HIPRABiotechServices #CDMO #Biotechnology #Pharmaceuticals #ContractManufacturing #DrugDevelopment #EUCompetitivenessCompass 

🔬 A study published in the Vaccine journal exposes safety and immunogenicity results of recombinant protein vaccine against #COVID19 at six months after boost. It is concluded that the vaccine induces a strong and sustained humoral and cellular response against the Wuhan, Beta, Delta, Omicron BA.1 and XBB.1.5 variants of SARS-CoV-2 compared to a boost with a mRNA-Based vaccine.  👉 Read the article here https://lnkd.in/eTy4krTa #HumanHealth #GlobalHealth